{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:10:40Z","timestamp":1791861040393,"version":"4.3.4"},"reference-count":101,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Reliable quantification in biological systems of endogenous low- and high-molecular substances, drugs and their metabolites, is of particular importance in diagnosis and therapy, and in basic and clinical research. The analytical characteristics of analytical approaches have many differences, including in core features such as accuracy, precision, specificity, and limits of detection (LOD) and quantitation (LOQ). Several different mathematic approaches were developed and used for the comparison of two analytical methods applied to the same chemical compound in the same biological sample. Generally, comparisons of results obtained by two analytical methods yields different quantitative results. Yet, which mathematical approach gives the most reliable results? Which mathematical approach is best suited to demonstrate agreement between the methods, or the superiority of an analytical method A over analytical method B? The simplest and most frequently used method of comparison is the linear regression analysis of data observed by method A (y) and the data observed by method B (x): y = \u03b1 + \u03b2x. In 1986, Bland and Altman indicated that linear regression analysis, notably the use of the correlation coefficient, is inappropriate for method-comparison. Instead, Bland and Altman have suggested an alternative approach, which is generally known as the Bland\u2013Altman approach. Originally, this method of comparison was applied in medicine, for instance, to measure blood pressure by two devices. The Bland\u2013Altman approach was rapidly adapted in analytical chemistry and in clinical chemistry. To date, the approach suggested by Bland\u2013Altman approach is one of the most widely used mathematical approaches for method-comparison. With about 37,000 citations, the original paper published in the journal The Lancet in 1986 is among the most frequently cited scientific papers in this area to date. Nevertheless, the Bland\u2013Altman approach has not been really set on a quantitative basis. No criteria have been proposed thus far, in which the Bland\u2013Altman approach can form the basis on which analytical agreement or the better analytical method can be demonstrated. In this article, the Bland\u2013Altman approach is re-valuated from a quantitative bioanalytical perspective, and an attempt is made to propose acceptance criteria. For this purpose, different analytical methods were compared with Gold Standard analytical methods based on mass spectrometry (MS) and tandem mass spectrometry (MS\/MS), i.e., GC-MS, GC-MS\/MS, LC-MS and LC-MS\/MS. Other chromatographic and non-chromatographic methods were also considered. The results for several different endogenous substances, including nitrate, anandamide, homoarginine, creatinine and malondialdehyde in human plasma, serum and urine are discussed. In addition to the Bland\u2013Altman approach, linear regression analysis and the Oldham\u2013Eksborg method-comparison approaches were used and compared. Special emphasis was given to the relation of difference and mean in the Bland\u2013Altman approach. Currently available guidelines for method validation were also considered. Acceptance criteria for method agreement were proposed, including the slope and correlation coefficient in linear regression, and the coefficient of variation for the percentage difference in the Bland\u2013Altman and Oldham\u2013Eksborg approaches.<\/jats:p>","DOI":"10.3390\/molecules28134905","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T02:09:17Z","timestamp":1687399757000},"page":"4905","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Mass Spectrometry-Based Evaluation of the Bland\u2013Altman Approach: Review, Discussion, and Proposal"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6320-0956","authenticated-orcid":false,"given":"Dimitrios","family":"Tsikas","sequence":"first","affiliation":[{"name":"Institute of Toxicology, Core Unit Proteomics, Hannover Medical School, 30623 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"key":"ref_1","unstructured":"Deming, W.E. (1943). Statistical Adjustment of Data, John Wiley and Sons."},{"key":"ref_2","unstructured":"Oldham, P.D. (1968). Measurement in Medicine: The Interpretation of Numerical Data, English Universities Press."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/clinchem\/19.1.49","article-title":"Use and interpretation of common statistical tests in method-comparison studies","volume":"19","author":"Westgard","year":"1973","journal-title":"Clin. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0009-8981(75)90199-0","article-title":"Applications of statistics in clinical chemistry. A critical evaluation of regression lines","volume":"64","author":"Wakkers","year":"1975","journal-title":"Clin. Chim. Acta"},{"key":"ref_5","first-page":"R94","article-title":"Fitting straight lines to experimental data","volume":"233","author":"Brace","year":"1977","journal-title":"Am. J. Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/clinchem\/25.3.432","article-title":"Incorrect least-squares regression coefficients in method-comparison analysis","volume":"25","author":"Cornbleet","year":"1979","journal-title":"Clin. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/clinchem\/26.7.1105a","article-title":"Linear regression analysis by Deming\u2019s method","volume":"26","author":"Smith","year":"1980","journal-title":"Clin. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/clinchem\/27.7.1311","article-title":"Evaluation of method-comparison data","volume":"27","author":"Eksborg","year":"1981","journal-title":"Clin. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2307\/2987937","article-title":"Measurement in Medicine: The analysis of method comparison studies","volume":"32","author":"Altman","year":"1983","journal-title":"Statistician"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/clinchem\/37.10.1669","article-title":"HPLC with enzymatic detection as a candidate reference method for serum creatinine","volume":"37","author":"Linnet","year":"1991","journal-title":"Clin. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/000456329202900512","article-title":"Method comparison\u2014A different approach","volume":"29","author":"Pollock","year":"1992","journal-title":"Ann. Clin. Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(95)91748-9","article-title":"Comparing methods of measurement: Why plotting difference against standard method is misleading","volume":"346","author":"Bland","year":"1995","journal-title":"Lancet"},{"key":"ref_14","unstructured":"National Committee for Clinical Laboratory Standards (1995). Method Comparison and Bias Estimation Using Patient Samples, Approved Guideline, NCCLS. NCCLS publication EP9-A."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/000456329603300101","article-title":"Analysis of method comparison studies","volume":"33","author":"Hollis","year":"1996","journal-title":"Ann. Clin. Biochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/clinchem\/43.11.2039","article-title":"Graphical interpretation of analytical data from comparison of a field method with reference method by use of difference plots","volume":"43","author":"Petersen","year":"1997","journal-title":"Clin. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/clinchem\/44.4.849","article-title":"Intrinsic and routine quality of serum total potassium measurement as investigated by split-sample measurement with an ion chromatography candidate reference method","volume":"44","author":"Thienpont","year":"1998","journal-title":"Clin. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/096228029900800204","article-title":"Measuring agreement in method comparison studies","volume":"8","author":"Bland","year":"1999","journal-title":"Stat. Methods Med. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00000539-200003000-00018","article-title":"Comparing methods of clinical measurement: Reporting standards for bland and altman analysis","volume":"90","author":"Mantha","year":"2000","journal-title":"Anesth. Analg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/clinchem\/48.5.799","article-title":"Application of the Bland-Altman plot for interpretation of method-comparison studies: A critical investigation of its practice","volume":"48","author":"Dewitte","year":"2002","journal-title":"Clin. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/clinchem\/48.5.801","article-title":"Commentary on quantifying agreement between two methods of measurement","volume":"48","author":"Altman","year":"2002","journal-title":"Clin. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2307\/2532051","article-title":"A concordance correlation coefficient to evaluate reproducibility","volume":"45","author":"Lin","year":"1989","journal-title":"Biometrics"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/1087057105285611","article-title":"The minimum significant ratio: A statistical parameter to characterize the reproducibility of potency estimates from concentration-response assays and estimation by replicate-experiment studies","volume":"11","author":"Eastwood","year":"2006","journal-title":"J. Biomol. Screen."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.jchromb.2009.01.027","article-title":"Review of statistical methodologies used to compare (bio)assays","volume":"877","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1440-1681.2009.05288.x","article-title":"Confidence in Altman-Bland plots: A critical review of the method of differences","volume":"37","author":"Ludbrook","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1440-1681.2009.05320.x","article-title":"Bland-Altman beyond the basics: Creating confidence with badly behaved data","volume":"37","author":"Woodman","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.11613\/BM.2015.015","article-title":"Understanding Bland Altman analysis","volume":"25","author":"Giavarina","year":"2015","journal-title":"Biochem. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/OPX.0000000000000513","article-title":"Exact parametric confidence intervals for Bland-Altman limits of agreement","volume":"92","author":"Carkeet","year":"2015","journal-title":"Optom. Vis. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/sim.6872","article-title":"How to regress and predict in a Bland-Altman plot? Review and contribution based on tolerance intervals and correlated-errors-in-variables models","volume":"35","author":"Francq","year":"2016","journal-title":"Stat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jclinepi.2015.02.015","article-title":"Adapted Bland-Altman method was used to compare measurement methods with unequal observations per case","volume":"68","author":"Hofman","year":"2015","journal-title":"J. Clin. Epidemiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"20150039","DOI":"10.1515\/ijb-2015-0039","article-title":"Sample size for assessing agreement between two methods of measurement by Bland-Altman method","volume":"12","author":"Lu","year":"2016","journal-title":"Int. J. Biostat."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1002\/sim.7352","article-title":"A framework for the meta-analysis of Bland-Altman studies based on a limits of agreement approach","volume":"36","author":"Tipton","year":"2017","journal-title":"Stat. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1177\/0962280216665419","article-title":"Confidence and coverage for Bland-Altman limits of agreement and their approximate confidence intervals","volume":"27","author":"Carkeet","year":"2018","journal-title":"Stat. Methods Med. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/jclinpath-2017-204520","article-title":"Improving validation methods for molecular diagnostics: Application of Bland-Altman, Deming and simple linear regression analyses in assay comparison and evaluation for next-generation sequencing","volume":"71","author":"Misyura","year":"2018","journal-title":"J. Clin. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0004563218806560","article-title":"ANNALS EXPRESS: Using the variance function to generalise Bland-Altman analysis","volume":"56","author":"Sadler","year":"2018","journal-title":"Ann. Clin. Biochem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.compbiomed.2018.06.020","article-title":"The Bland-Altman range of agreement: Exact interval procedure and sample size determination","volume":"100","author":"Jan","year":"2018","journal-title":"Comput. Biol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0009-8981(84)90274-2","article-title":"Mass spectrometry and clinical chemistry","volume":"139","author":"Hill","year":"1984","journal-title":"Clin. Chim. Acta"},{"key":"ref_38","first-page":"433","article-title":"International Federation of Clinical Chemistry (IFCC), Office for Reference Methods and Materials (ORMM). Methodological aspects on quantitative mass spectrometry used for accuracy control in clinical chemistry","volume":"23","author":"Lawson","year":"1985","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0378-4347(98)00210-2","article-title":"Application of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry to assess in vivo synthesis of prostaglandins, thromboxane, leukotrienes, isoprostanes and related compounds in humans","volume":"717","author":"Tsikas","year":"1988","journal-title":"J. Chromatogr. B"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1056\/NEJMoa025225","article-title":"Screening newborns for inborn errors of metabolism by tandem mass spectrometry","volume":"348","author":"Wilcken","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0378-4347(95)00212-2","article-title":"Application of tandem mass spectrometry for the analysis of long-chain carboxylic acids","volume":"671","author":"Kuksis","year":"1995","journal-title":"J. Chromatogr. B"},{"key":"ref_42","unstructured":"Oehme, M. (1996). Praktische Einf\u00fchrung in die GC-MS-Analytik mit Quadrupolen, H\u00fcthig."},{"key":"ref_43","unstructured":"Busch, K.L., Glish, G.L., and McLuckey, S.A. (1998). Mass Spectrometry\/Mass Spectrometry, VCH Publishers."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Gross, J.H. (2004). Mass Spectrometry, Springer.","DOI":"10.1007\/3-540-36756-X"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Watson, J.T., and Sparkman, O.D. (2007). Introduction in Mass Spectrometry, Wiley. [4th ed.].","DOI":"10.1002\/9780470516898"},{"key":"ref_46","unstructured":"Jennings, K.R. (2012). A History of European Mass Spectrometry, IM Publications LLP."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mas.21396","article-title":"Mass spectrometry and 3-nitrotyrosine: Strategies, controversies, and our current perspective","volume":"33","author":"Tsikas","year":"2014","journal-title":"Mass Spectrom. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/jms.3038","article-title":"Good mass spectrometry and its place in good science","volume":"47","author":"Duncan","year":"2012","journal-title":"J. Mass Spectrom."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.jchromb.2008.09.030","article-title":"Key aspects of analytical method validation and linearity evaluation","volume":"877","author":"Araujo","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jps.2600810324","article-title":"Analytical methods validation: Bioavailability, bioequivalence, and pharmacokinetic studies","volume":"81","author":"Shah","year":"1992","journal-title":"Pharmac. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"E109","DOI":"10.1208\/aapsj0901011","article-title":"Key elements of bioanalytical method validation for small molecules","volume":"9","author":"Bansal","year":"2007","journal-title":"AAPS J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpba.2018.12.030","article-title":"Bioanalytical method validation: New FDA guidance vs. EMA guideline. Better or worse?","volume":"165","author":"Kaza","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_53","first-page":"1","article-title":"Requirements for initial assay validation and publication in J. Chromatography B","volume":"707","author":"Lindner","year":"1998","journal-title":"J. Chromatogr. B"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2007.10.039","article-title":"Summary of a recent workshop\/conference report on validation and implementation of bioanalytical methods: Implications on manuscript review in the Journal of Chromatography B","volume":"860","author":"Bischoff","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.4155\/bio-2019-0270","article-title":"2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs (Part 2\u2014Recommendations on 2018 FDA BMV Guidance, 2019 ICH M10 BMV Draft Guideline and Regulatory Agencies\u2019 Input on Bioanalysis, Biomarkers and Immunogenicity)","volume":"11","author":"Booth","year":"2019","journal-title":"Bioanalysis"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jchromb.2018.07.005","article-title":"Bioanalytical method validation of endogenous substances according to guidelines by the FDA and other organizations: Basic need to specify concentration ranges","volume":"1093\u20131094","author":"Tsikas","year":"2018","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jchromb.2009.02.029","article-title":"A proposal for comparing methods of quantitative analysis of endogenous compounds in biological systems by using the relative lower limit of quantification (rLLOQ)","volume":"877","author":"Tsikas","year":"2009","journal-title":"Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0378-4347(99)00244-3","article-title":"Gas chromatographic-tandem mass spectrometric quantification of human plasma and urinary nitrate after its reduction to nitrite and derivatization to the pentafluorobenzyl derivative","volume":"731","author":"Tsikas","year":"1999","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1373\/clinchem.2004.032649","article-title":"Mass spectrometry-validated HPLC method for urinary nitrate","volume":"50","author":"Tsikas","year":"2004","journal-title":"Clin. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1021\/ac9913255","article-title":"Simultaneous derivatization and quantification of the nitric oxide metabolites nitrite and nitrate in biological fluids by gas chromatography\/mass spectrometry","volume":"72","author":"Tsikas","year":"2000","journal-title":"Anal. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s002400000141","article-title":"Determination of nitric oxide metabolites by means of the Griess assay and gas chromatography-mass spectrometry in the cavernous and systemic blood of healthy males and patients with erectile dysfunction during different functional conditions of the penis","volume":"28","author":"Becker","year":"2000","journal-title":"Urol. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s00726-015-1991-4","article-title":"Asymmetric dimethylarginine (ADMA) in human blood: Effects of extended haemodialysis in the critically ill patient with acute kidney injury, protein binding to human serum albumin and proteolysis by thermolysin","volume":"47","author":"Sitar","year":"2015","journal-title":"Amino Acids"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jchromb.2003.09.001","article-title":"Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography-tandem mass spectrometry as methyl ester tri(N-pentafluoropropionyl) derivative","volume":"798","author":"Tsikas","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1515\/CCLM.2004.257","article-title":"Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay","volume":"42","author":"Schulze","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1373\/clinchem.2005.056788","article-title":"Determination of asymmetric dimethylarginine: Liquid chromatography-mass spectrometry or ELISA?","volume":"51","author":"Westphal","year":"2005","journal-title":"Clin. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jchromb.2005.09.023","article-title":"Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum","volume":"828","author":"Valtonen","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jchromb.2006.12.009","article-title":"Asymmetric dimethylarginine-comparison of HPLC and ELISA methods","volume":"850","author":"Trefil","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/j.jchromb.2009.04.016","article-title":"Targeted stable-isotope dilution GC-MS\/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma","volume":"877","author":"Zoerner","year":"2009","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jchromb.2011.06.025","article-title":"Simultaneous UPLC-MS\/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: Minimization of matrix-effects, 2AG\/1AG isomerization and degradation by toluene solvent extraction","volume":"883\u2013884","author":"Zoerner","year":"2012","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s00726-014-1774-3","article-title":"GC-MS and GC-MS\/MS measurement of the cardiovascular risk factor homoarginine in biological samples","volume":"46","author":"Kayacelebi","year":"2014","journal-title":"Amino Acids"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00726-015-2037-7","article-title":"Measurement of homoarginine in human and mouse plasma by LC-MS\/MS and ELISA: A comparison and a biological application","volume":"47","author":"Cordts","year":"2015","journal-title":"Amino Acids"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0076-6879(99)00106-8","article-title":"Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress","volume":"300","author":"Morrow","year":"1998","journal-title":"Methods Enzymol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/clinchem\/47.11.1974","article-title":"Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes","volume":"47","author":"Devaraj","year":"2001","journal-title":"Clin. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1194\/jlr.M700097-JLR200","article-title":"Quantitation of isoprostane isomers in human urine from smokers and nonsmokers by LC-MS\/MS","volume":"48","author":"Yan","year":"2007","journal-title":"J. Lip. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1440-1681.1997.tb01807.x","article-title":"Comparing methods of measurements","volume":"24","author":"Ludbrook","year":"1997","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_76","unstructured":"Daniel, W.W. (1978). W.W. Biostatistics: A Foundation for Analysis in the Health Sciences, John Wiley & Sons. [2nd ed.]."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.niox.2005.05.008","article-title":"Local nitric oxide levels reflect the degree of allergic airway inflammation after segmental allergen challenge in asthmatics","volume":"13","author":"Erpenbeck","year":"2005","journal-title":"Nitric Oxide"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1570-0232(02)00751-1","article-title":"Accurate quantification of basal plasma levels of 3-nitrotyrosine and 3-nitrotyrosinoalbumin by gas chromatography-tandem mass spectrometry","volume":"784","author":"Tsikas","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1570-0232(03)00457-4","article-title":"Divergence in urinary 8-iso-PGF(2alpha) (iPF(2alpha)-III, 15-F(2t)-IsoP) levels from gas chromatography-tandem mass spectrometry quantification after thin-layer chromatography and immunoaffinity column chromatography reveals heterogeneity of 8-iso-PGF(2alpha). Possible methodological, mechanistic and clinical implications","volume":"794","author":"Tsikas","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1373\/clinchem.2003.024141","article-title":"Simplified HPLC method for urinary and circulating creatinine","volume":"50","author":"Tsikas","year":"2004","journal-title":"Clin. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ab.2008.04.018","article-title":"A critical review and discussion of analytical methods in the L-arginine\/nitric oxide area of basic and clinical research","volume":"379","author":"Tsikas","year":"2008","journal-title":"Anal. Biochem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jchromb.2006.07.024","article-title":"HPLC analysis of ADMA and other methylated L-arginine analogs in biological fluids","volume":"851","author":"Teerlink","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jchromb.2006.09.023","article-title":"An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: Methodological considerations","volume":"851","author":"Horowitz","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jchromb.2006.07.038","article-title":"Chromatographic-mass spectrometric methods for the quantification of L-arginine and its methylated metabolites in biological fluids","volume":"851","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bbalip.2011.08.004","article-title":"Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: A comprehensive review from an analytical and biological perspective","volume":"1811","author":"Zoerner","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jchromb.2014.03.017","article-title":"Analysis of eicosanoids by LC-MS\/MS and GC-MS\/MS: A historical retrospect and a discussion","volume":"964","author":"Tsikas","year":"2014","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MCO.0000000000000889","article-title":"Homoarginine in health and disease","volume":"26","author":"Tsikas","year":"2023","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/157341207779802340","article-title":"Mass spectrometric analysis of F2-isoprostanes: Markers and mediators in human disease","volume":"3","author":"Schwedhelm","year":"2007","journal-title":"Curr. Pharm. Anal."},{"key":"ref_89","first-page":"e49","article-title":"8-Iso-Prostaglandin F2 as a Risk Marker in Patients With Coronary Heart Disease","volume":"109","author":"Vassalle","year":"2004","journal-title":"Circulation"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1373\/clinchem.2006.074989","article-title":"Isoprostane measurement in plasma and urine by liquid chromatography-mass spectrometry with one-step sample preparation","volume":"53","author":"Sircar","year":"2007","journal-title":"Clin. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0378-4347(00)00236-X","article-title":"Tandem mass spectrometric quantification of 8-iso-prostaglandin F2alpha and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2alpha in human urine","volume":"744","author":"Schwedhelm","year":"2000","journal-title":"J. Chromatogr. B"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jchromb.2006.07.054","article-title":"Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: Appraisal of the Griess reaction in the L-arginine\/nitric oxide area of research","volume":"851","author":"Tsikas","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ab.2016.10.021","article-title":"Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges","volume":"524","author":"Tsikas","year":"2017","journal-title":"Anal. Biochem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jchromb.2018.05.001","article-title":"Analysis of malondialdehyde in human plasma samples through derivatization with 2,4-dinitrophenylhydrazine by ultrasound-assisted dispersive liquid-liquid microextraction-GC-FID approach","volume":"1089","author":"Malaei","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/OPX.0000000000001465","article-title":"A Review of the Use of Confidence Intervals for Bland-Altman Limits of Agreement in Optometry and Vision Science","volume":"97","author":"Carkeet","year":"2020","journal-title":"Optom. Vis. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1177\/1358836X0501000113","article-title":"Quantification of ADMA: Analytical approaches","volume":"10","author":"Schwedhelm","year":"2005","journal-title":"Vasc. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1016\/j.jchromb.2010.04.025","article-title":"GC-MS determination of creatinine in human biological fluids as pentafluorobenzyl derivative in clinical studies and biomonitoring: Inter-laboratory comparison in urine with Jaff\u00e9, HPLC and enzymatic assays","volume":"878","author":"Tsikas","year":"2010","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/ki.1995.363","article-title":"The standard peritoneal permeability analysis: A tool for the assessment of peritoneal permeability characteristics in CAPD patients","volume":"48","author":"Pannekeet","year":"1995","journal-title":"Kidney Int."},{"key":"ref_99","unstructured":"(2023, March 01). Bioanalytical Method Validation\u2014Scientific Guideline. Available online: https:\/\/www.ema.europa.eu\/en\/bioanalytical-method-validation-scientific-guideline."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/j.jchromb.2008.12.062","article-title":"Specific GC-MS\/MS stable-isotope dilution methodology for free 9- and 10-nitro-oleic acid in human plasma challenges previous LC-MS\/MS reports","volume":"877","author":"Tsikas","year":"2009","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/13\/4905\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:58:22Z","timestamp":1760126302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/13\/4905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":101,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["molecules28134905"],"URL":"https:\/\/doi.org\/10.3390\/molecules28134905","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]}}}